Page last updated: 2024-09-02

fingolimod hydrochloride and Blood Diseases

fingolimod hydrochloride has been researched along with Blood Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrero, F; En Representacion de Los Investigadores Del Estudio Ms Next, ERLIDEMN; Garcia, E; Mallada-Frechin, J; Martinez-Gines, ML; Marzo-Sola, ME; Meca-Lallana, V; Ricart, J	1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Blood Diseases

Article	Year
[Efficacy and safety of fingolimod in routine clinical practice in patients with relapsing-remitting multiple sclerosis in Spain: an intermediate analysis of the MS NEXT study]. Revista de neurologia, 2018, Sep-01, Volume: 67, Issue:5 Topics: Adult; Disease Progression; Drug Resistance; Drug Substitution; Female; Fingolimod Hydrochloride; Gastrointestinal Diseases; Heart Diseases; Hematologic Diseases; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Retrospective Studies	2018

Article

Year

[Efficacy and safety of fingolimod in routine clinical practice in patients with relapsing-remitting multiple sclerosis in Spain: an intermediate analysis of the MS NEXT study].

Revista de neurologia, 2018, Sep-01, Volume: 67, Issue:5

Topics: Adult; Disease Progression; Drug Resistance; Drug Substitution; Female; Fingolimod Hydrochloride; Gastrointestinal Diseases; Heart Diseases; Hematologic Diseases; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Retrospective Studies

2018